Twist Bioscience stock jumps 4.6 percent to 102.88 as upbeat mood persists, Twist Bioscience tweets

Twist Bioscience stock jumps 4.6 percent to 102.88 as upbeat mood persists, Twist Bioscience tweets
Twist Bioscience surges 4.60% today

Twist Bioscience is reflecting on the first half of 2026 with a focus on sentiment and outlook.

Highlights

  • TWST maintains strong bullish momentum across all timeframes, trading well above critical moving average support levels.
  • Technical indicators confirm buy signals and trend strength, but multiple overbought readings suggest potential for near-term exhaustion.
  • TWST is projected to consolidate between $97.00 and $106.00, with a breakout above $106.00 signaling further upside risk.

The company referenced a 'vibe check' in a tweet and invited followers to choose which feeling describes the year so far. Details are being clarified.

Bullish momentum persists as price extends far above support zone

TWST is trading at $102.88, well above its MA-20 at $81.96, MA-50 at $68.08, and MA-200 at $45.59. This setup confirms persistent bullish momentum across short-, medium-, and long-term timeframes. The Ichimoku Kijun sits at $80.39, acting as immediate support under current price action. Near-term support is clustered at the Kijun ($80.39), with key support at MA-50 ($68.08). The first resistance area is near MA-5/MA-10 ($97.82–$91.46), but with price extended, key resistance is marked by this week’s high at $104.11.

Overbought signals intensify after strong rally tests weekly resistance

Momentum signals on D1 such as MACD and ADX support continued upside, with both indicating a buy bias. However, RSI at 79.00, CCI at 137.13, Stoch RSI at 98.24, and BBP at 13.68 all show clear overbought conditions, warning of short-term exhaustion as buyers strongly dominate the session. The Awesome Oscillator also supports the prevailing trend. TWST has risen $3.04 (3.04%) over the past week, trading at $102.88 versus $99.84 a week ago. The current price is at the very top of the weekly range, and weekly volatility stands at 21.77%. The stock is consolidating near resistance after a strong rally, with momentum confirmed but overbought signals flashing caution.

Probability favors consolidation as bullish outlook meets volatility

Looking ahead, the projected price range for the coming week is $97.00 to $106.00, reflecting the sharp uptrend and recent high volatility but normalized to keep within 8% of the current price. This range is near the 52-week high of $104.11 and far above the annual low of $23.30. On the W1 chart, all key momentum indicators (RSI, ADX, MACD, MA-50) are bullish. This implies a very high probability (more than 80%) of price increase, while the odds of a reversal are very low. The baseline scenario anticipates price consolidation between $97.00 and $106.00. In the bullish case, a sustained breakout above $106.00 could open room toward new highs as buying pressure resumes. In a bearish scenario, a pullback below $97.00 may follow if overbought pressures trigger profit-taking, but multiple layers of support remain in place.

Previously it was reported that Twist Bioscience was exhibiting strong bullish momentum, with technical analysis pointing toward continued upside. This article adds a new dimension by reassessing the prevailing scenario for TWST, highlighting a key level that traders should monitor as market conditions develop.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.